Somatic vs. Hereditary Mutations: What's the Difference, and Why Should You Care?

When people talk about genetic mutations and cancer risk, they often use the terms "somatic" and "hereditary" (or "germline") mutations. These are fundamentally different types of genetic changes with very different implications for your health and your family's health. Understanding the distinction is essential for making sense of genetic testing results and cancer risk information.

What Are Germline (Hereditary) Mutations?

Germline mutations are genetic changes that are present in every cell of your body from the moment of conception. They are inherited from one or both parents and can be passed on to your children. Because they're present in every cell, they can be detected from any tissue — including a simple saliva or blood sample.

Key Characteristics of Germline Mutations

• Present in every cell of the body
• Inherited from parents; can be passed to children
• Detectable from saliva, blood, or any tissue
• Increase lifetime risk of specific diseases (not certainty)
• Have implications for family members who may share the same mutation

Examples of Clinically Significant Germline Mutations

• BRCA1/BRCA2: Significantly increase lifetime risk of breast, ovarian, and other cancers
• Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2): Increase risk of colorectal, endometrial, and other cancers
• TP53 (Li-Fraumeni syndrome): Increases risk of multiple cancer types from childhood
• APC (Familial Adenomatous Polyposis): Near-certain risk of colorectal cancer without intervention

What Are Somatic Mutations?

Somatic mutations are genetic changes that arise in specific cells during a person's lifetime — not inherited, not present at birth, and not present in every cell. They accumulate due to DNA replication errors, environmental exposures (UV radiation, carcinogens, tobacco), and random chance. Most cancers are driven primarily by somatic mutations.

Key Characteristics of Somatic Mutations

• Present only in specific cells or tissues (not the whole body)
• Not inherited; cannot be passed to children
• Detectable only from tumor tissue (not from saliva or blood)
• Drive cancer development and progression
• Can be targeted by specific cancer therapies

Examples of Clinically Significant Somatic Mutations

• EGFR mutations in lung cancer: Targetable with EGFR inhibitors
• KRAS mutations in colorectal cancer: Predict resistance to certain therapies
• HER2 amplification in breast cancer: Targetable with HER2-directed therapies
• BRAF V600E in melanoma: Targetable with BRAF inhibitors

Why the Distinction Matters

The type of mutation determines what test you need, what the results mean for you and your family, and what actions are appropriate. Germline testing (from saliva or blood) identifies inherited risk — relevant for prevention, screening, and family planning. Tumor genomic profiling (from biopsy tissue) identifies somatic mutations — relevant for treatment selection in diagnosed cancer.

FAQs

If I have a BRCA mutation, does that mean I have cancer?

No. A germline BRCA mutation increases your lifetime risk of certain cancers but does not mean you have cancer or will definitely develop it. It's a risk factor that guides more intensive screening and preventive options.

Can a somatic mutation become hereditary?

No. Somatic mutations occur in body cells (somatic cells), not in eggs or sperm (germline cells). They cannot be passed to children.